Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

Chioncel, Ovidiu, Lainscak, Mitja, Seferovic, Petar M., Anker, Stefan D., Crespo-Leiro, Maria G., Harjola, Veli-Pekka, Parissis, John, Laroche, Cecile +10 more·2017·European Journal of Heart Failure

Cited by (930)

Items 601–700 of 930

  1. When more is less and less is more: Is there an additional value of NT-proBNP in risk stratification in heart failure?
    Petar M Seferovic, Marija M. Polovina · 2018 · European Journal of Preventive Cardiology
  2. Hospitalisation and life support in the year before and during heart transplantation: a French national study
    C. Cantrelle, Richard Dorent, Camille Legeai, Thibaud Damy, Olivier H. Bastien, Philippe Tuppin · 2018 · Open Heart
  3. Similar predictive value of six-minute walking distance and B-type natriuretic peptide in heart failure with reduced to mid-range ejection fraction
    Angela Beatrice Scardovi, Renata De Maria, Gian Giacomo Galeotti, Pompilio Massimo Faggiano, Luca Arcari, Stefano Ghio, Pier Luigi Temporelli, Andrea Rossi, Giovanna Magni, Anca Simioniuc et al. · 2019 · Monaldi Archives for Chest Disease
  4. Long-term outcome of carvedilol therapy in Japanese patients with nonischemic heart failure
    Kimiko Nagara, Atsushi Suzuki, Tsuyoshi Shiga, Nobuhisa Hagiwara · 2020 · Heart and Vessels
  5. Circulating Soluble ST2 Predicts All-Cause Mortality in Severe Heart Failure Patients with an Implantable Cardioverter Defibrillator
    Zhi-wei Hou, Haibo Yu, Yanchun Liang, Yang Gao, Guoqing Xu, Min Wu, Zhu Mei, Zulu Wang, Zhiguo Li, Yuying Li et al. · 2020 · Cardiology Research and Practice
  6. Revival and Revision of Right Ventricular Assessment by Machine Learning
    David Ouyang, Susan C. Cheng · 2022 · JACC. Cardiovascular imaging
  7. Understanding the Pathophysiology of Heart Failure with Mid-Range Ejection Fraction: A Comprehensive Narrative Review
    Mohammadjavad Sotoudeheian, SeyedAhmad Hoseini, Seyed‐Mohamad‐Sadegh Mirahmadi · 2023 · Preprints.org
  8. Clinician Attitudes Towards Telemonitoring for Heart Failure Care: Opportunities for Design Research
    Vugs, Suzanne, Scholte, Niels Tjeerd Benjamin, Markopoulos, Panos, Ronner, Eelko · 2023 · Extended Abstracts of the 2023 CHI Conference on Human Factors in Computing Systems
  9. No effects of cardiac resynchronization therapy and right ventricular pacing on the right ventricle in patients with heart failure and atrial fibrillation
    Ewa Majos, Alicja Kraska, Ilona Kowalik, Edyta Smolis Bąk, Piotr Lipiec, Jarosław Damian Kasprzak, Hanna Szwed, Rafał Dąbrowski · 2020 · Scandinavian Cardiovascular Journal
  10. The diagnostic value of peroxisome proliferator-activated receptor-γ coactivator-1α in identifying different chronic heart failure phenotypes
    Shiwen Zhang, Yufei Zhou, Yanfang Ma, Zhan Li, Yinglong Hou · 2022 · Frontiers in Cardiovascular Medicine
  11. Molecular mechanisms of inflammation in the development of heart failure: A review
    Yuri I. Buziashvili, Асымбекова Эльмира Уметовна, Тугеева Эльвина Фаатовна, Рахимов Акмал Закрияевич, Л.С. Шахназарян, Акилджонов Фирдавсджон Рустамджонович · 2023 · Consilium Medicum
  12. Clinical features and two-year outcomes in systemic lupus erythematosus patients with heart failure and reduced, mid-range and preserved ejection fractions
    Zhe Li, Shuhua Zhu, Wenjun Tang, Haitao Zhang, Weibo Le, Song Luo, Chen Zhou, Yang Wang, Shutian Xu, Weixin Hu et al. · 2024 · Lupus
  13. Association between GLIM diagnosed malnutrition and 18‐month mortality in hospitalized adults with congestive heart failure: A prospective cohort study
    Ruoshu Duan, Suxiu Chen, Su‐Xia Li, Jie Ding, Lei Wang, Yamin Li, Jingjing Ren, Sujing Jiang · 2025 · Journal of Parenteral and Enteral Nutrition
  14. Prognostic Value of the NT-proBNP-to-Albumin Ratio (NTAR) for In-Hospital Mortality in Chronic Heart Failure Patients
    Liviu Cristescu, Răzvan Gheorghiţă Mareş, Dragos-Gabriel Iancu, Marius Mărușteri, Andreea Varga, Ioan Ţilea · 2025 · Biomedicines
  15. Prognostic impact of rheumatic diseases in patients with heart failure with mildly reduced ejection fraction
    Michelle Goertz, Tobias Schupp, Jonas Dudda, Kathrin Weidner, Felix Lau, Alexander Schmitt, Noah Abel, Mohammad Abumayyaleh, Henning Johann Steffen, Harald F. Langer et al. · 2025 · Clinical Research in Cardiology
  16. Heart failure in Southern Sweden (HISS): a cross-sectional analysis of primary care patients’ characteristics and physicians’ adherence to guideline-directed medical therapy
    Katarina Söderberg, Lo Kronestedt Lundevall, Thomas Lindow, Oscar Ö. Braun, J Gustav Smith, Kristina Sundquist, Veronica Milos Nymberg · 2025 · BMJ Open
  17. Clinical Features and Outcomes of Patients with Heart Failure and Advanced Chronic Kidney Disease
    María Anguita Gámez, Javier Herrera Flores, Juan L. Bonilla‐Palomas, Alejandro Recio Mayoral, Rafael González Manzanares, Juan Carlos Castillo, José López Aguilera, Javier Muñiz, Manuel P. Anguita-Sánchez · 2025 · Journal of Clinical Medicine
  18. Risk Stratification Tools in Acute Heart Failure and Their Roles in Personalized Follow-Up
    Vittoria Rizzello, Samuela Carigi, Renata De Maria, Maria Denitza Tinti, Raul Limonta, Francesco Orso, Matteo Bianco, Luisa De Gennaro, Maria Vittoria Matassini, Paolo Manca et al. · 2025 · Journal of Clinical Medicine
  19. Prevalence and prognosis of multimorbidity in heart failure with mildly reduced ejection fraction
    Marielen Reinhardt, Michael Behnes, Mohammad Abumayyaleh, Thomas Bertsch, Michelle Goertz, Noah Abel, Alexander Schmitt, Felix Lau, Jonas Dudda, Kathrin Weidner et al. · 2026 · Clinical Research in Cardiology
  20. Association between the TAPSE/PASP ratio and exercise capacity in heart transplant candidates with advanced heart failure
    Rezzan Deniz Acar, Murat Karaçam, Seda Tanyeri, Azmican Kaya, Barkın Kültürsay, Deniz Mutlu, Süleyman Çağan Efe, Gülümser Sevgin Halil, Özgür Yaşar Akbal, Cem Doğan et al. · 2026 · Frontiers in Cardiovascular Medicine
  21. Real-world evidence with dapagliflozin in heart failure with reduced ejection fraction in Central Eastern Europe and the Baltic region (EVOLUTION-HF CEE-BA Study)
    Przemysław Leszek, Zoltan Csanádi, Ivan Tomov Gruev, Tiina Uuetoa, Diana Žaliaduonytė, Davor Milicić, Kārlis Trušinskis, Jūratė Baukienė, Alexandru Mihai Isvoranu, Ovidiu Chioncel · 2026 · ESC Heart Failure
  22. European Journal of Heart Failure International Expert Position Paper—Utilization, optimization, and clinical benefits of steroidal mineralocorticoid receptor antagonists in heart failure with a reduced ejection fraction
    Michael Böhm, J. Abdullakutty, Johann K Bauersachs, Udo Bavendiek, Antoni Bayés‐Genís, Kuntal Bhattacharyya, Jan Biegus, Biykem Bozkurt, Javed Butler, Ezhilan Janakiraman et al. · 2026 · European Journal of Heart Failure
  23. Heart Failure With Mildly Reduced Ejection Fraction: A Heart Failure Society of America Scientific Statement
    Jane E. Wilcox, Lars H Lund, Zachary L. Cox, Jennifer E. Ho, Carolyn S.P. Lam, Kavita Sharma, Barry A. Borlaug · 2026 · Journal of Cardiac Failure
  24. Two Phenotypes, One Prognosis: Period-Specific Mortality and Prediction of Post-Discharge Events in Acute Heart Failure
    Georgios Aletras, Kostas Stylianou, Maria E. Marketou, M Stratinaki, Alexandra Papayiannaki, Yannis Pantazis, Michalis Hamilos, Emmanouil G Foukarakis · 2026 · Journal of Cardiovascular Development and Disease
  25. Clinical and pathogenetic features of chronic heart failure with mid-range ejection fraction
    N. V. Shlyakhtina, E. A. Antonenok, A. O. Galantsev · 2021 · Сибирский журнал клинической и экспериментальной медицины
  26. Strategic Multimodal Non-Invasive Assessment of Cardiac Performance in Patients with Heart Failure
    Mi‐Jeong Kim, Jung Sun Cho, Kyusup Lee, Woojin Kwon, Chaeryeon Ohn, Myunhee Lee, Dae‐Won Kim, Tae‐Seok Kim, Mahn‐Won Park · 2023 · ESC Heart Failure
  27. Differences in clinical outcomes, health care resource utilization and costs in heart failure patients according to left ventricular ejection fraction
    Juan Carlos López‐Azor, Juan F. Delgado, Jorge Vélez, Rocío Rodríguez, Jorge Solı́s, Manuel del Oro, Carmen Ortega, Rafael Salguero Bodes, Beatriz Palacios, Lourdes Vicent et al. · 2023 · Revista Española de Cardiología (English Edition)
  28. Impact of Age on Characteristics, Performance Measures and Outcomes of Inpatients for Heart Failure in Beijing, China
    Yuan Cong, Liu He, Xin Du, Chao Jiang, Shijun Xia, Xin Zhao, Songnan Li, Caihua Sang, Deyong Long, Jianzeng Dong et al. · 2023 · ESC Heart Failure
  29. In-hospital complications after MitraClip in patients with heart failure and preserved versus reduced ejection fraction in the United States
    Chayakrit Krittanawong, Joshua Hahn, Hafeez Ul Hassan Virk, Dhrubajyoti Bandyopadhyay, Neelkumar Patel, Ujjwal Rastogi, Zhen Wang, Mahboob Alam, Hani M. Jneid, Samin Kumar Sharma et al. · 2023 · Cardiovascular revascularization medicine
  30. Parameters of the mitral apparatus in patients with ischemic and nonischemic dilated cardiomyopathy
    J Presume, Mariana Sousa Paiva, Sara Lopes Guerreiro, Regina Ribeiras · 2023 · Journal of International Medical Research
  31. The Role of NAD+ in Myocardial Ischemia-induced Heart Failure in Sprague-dawley Rats and Beagles
    Zuowei Pei, Chenguang Yang, Ying Guo, Min Dong, Fang Wang · 2024 · Current Pharmaceutical Biotechnology
  32. Risk of malignant ventricular arrhythmias in patients with mildly to moderately reduced ejection fraction after permanent pacemaker implantation
    Matthew Shijie Dai, Connor Peterson, Udi Chorin, Orly Leiva, Moshe Katz, Hend Sliman, Anthony Aizer, Chirag R. Barbhaiya, Scott Bernstein, Douglas Holmes et al. · 2024 · Heart Rhythm
  33. Improving the quality of healthcare. Results of the SEC-Excelente accreditation program in heart failure of the Spanish Society of Cardiology
    Manuel Anguita Sánchez, Alejandro Recio Mayoral, Luis Rodrı́guez Padial · 2024 · Revista Española de Cardiología (English Edition)
  34. Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany
    Alexander Michel, Coralie Lecomte, Christoph Ohlmeier, Hanaya Raad, Frederike Basedow, Dennis Häckl, Dominik Beier, Thomas Evers · 2024 · American Journal of Cardiovascular Drugs
  35. The Importance of Lung Ultrasound and IGFBP7 (Insulin-like Growth Factor Binding Protein 7) Assessment in Diagnosing Patients with Heart Failure
    Anna Maria Szyszkowska, Tomasz Olesiewicz, Izabela Płońska-Korabiewska, Ewa Tarasiuk, Barbara Olesiewicz, Małgorzata Knapp, Rafał Śledziewski, Bożena Sobkowicz, Anna Lisowska · 2024 · Journal of Clinical Medicine
  36. HFrEF, HFmrEF, and HFpEF: Are They a Continuum or Different Faces of a Syndrome?
    Even Edilce Mol, Camila Hartmann, Lídia Zytynski Moura · 2024 · International Journal of Cardiovascular Sciences
  37. Консенсус експертів Всеукраїнської асоціації кардіологів України і Всеукраїнської асоціації фахівців із серцевої недостатності щодо нового індивідуалізованого підходу до лікування пацієнтів із прогресуючим перебігом хронічної серцевої недостатності
    Leonid Georgievich Voronkov, Марина Миколаївна Долженко, Oleg J. Zharinov, H. V. Zaichenko, D. D. Ivanov, Olena Koval, Ye. Ya. Kravcheniuk, Д. А. Лашкул, Alexander N. Parkhomenko, Андрій Різниченко et al. · 2024 · Ukrainian Journal of Cardiology
  38. Clinical and Demographic Characteristics of Patients Hospitalized for Decompensated Heart Failure with Extremely High NT-proBNP Levels
    Ruxandra Christodorescu, Daniel Miron Brie, Alina Diduța Brie, Samuel Nistor, Alexandru Tîrziu, Dragomir Angela, Cristian Mornoş, Simona Ruxanda Dragan, Daniel Duda-Seiman, Adina Pop Moldovan et al. · 2024 · Diagnostics
  39. Distinguishing between mortality rates for heart failure with preserved versus reduced ejection fraction
    Haoyi Zheng · 2024 · The Lancet Global Health
  40. Mineralocorticoid receptor antagonist (MRA) use in UK heart failure care: a national primary care cohort study
    Rory Maclean, Yang Chen, R Thomas Lumbers, Anoop D Shah · 2025 · Heart
  41. Predictors and prognosis of progression of aortic valve stenosis in patients hospitalized with heart failure with mildly reduced ejection fraction
    Noah Abel, Michael Behnes, Alexander Schmitt, Marielen Reinhardt, Felix Lau, Kathrin Weidner, Mohamed Ayoub, Kambis Mashayekhi, Thomas Bertsch, İbrahim Akın et al. · 2025 · Cardiovascular revascularization medicine
  42. Prognostic impact of left ventricular dilatation in heart failure with mildly reduced ejection fraction
    Henning Johann Steffen, Michael Behnes, Jonas Dudda, Alexander Schmitt, Noah Abel, Felix Lau, Marielen Reinhardt, Thomas Bertsch, Kathrin Weidner, Daniel Duerschmied et al. · 2025 · European Journal of Internal Medicine
  43. Effectiveness and safety analysis of Qifu Yixin Prescription for the treatment of heart failure with preserved ejection fraction: study protocol for a randomized, double-blind, placebo-controlled clinical trial
    Zhaohui Xu, Yinqin Hu, Jiahui Yang, Qiqi Wan, Xinyu Zhang, Weilin Wang, Yongming Liu · 2025 · BMC Complementary Medicine and Therapies
  44. Baseline characteristics of outpatients with heart failure according to phenotype: preliminary analysis from SMYRNA-HF registry
    Bihter Şentürk, Ahmet Çelik, Lütfü Bekar, Umut Uyan, Selcen Yakar Tülüce, Hakan Güneş, Murat Kerkütlüoğlu, Ali Çoner, Barış Kılıçaslan, Nurullah Çetin et al. · 2022 · The European Research Journal
  45. Assessment of left ventricular systolic function using a single-channel ECG monitor with photoplethysmography based on machine learning models
    Zh.N. Sagirova, Natalia Kuznetsova, А. Yu. Suvorov, Daria G. Gognieva, V. M. Kulikov, P. Sh. Chomakhidze, Denis A. Andreev, Philipp Kopylov · 2023 · Russian Journal of Cardiology and Cardiovascular Surgery
  46. Sobrevida em 10 Anos de Pacientes com Insuficiência Cardíaca com FEVE 40-59%: Uma Classificação Fenotípica Viável?
    Luiz Cláudio Danzmann, Luiz Carlos Bodanese, Aline Petracco Petzold, Anna Paula Tscheika, Ellen Hettwer Magedanz, Lucas Célia Petersen, Evgeny Belyavskiy, Fernanda Lourega Chieza · 2023 · Arquivos Brasileiros de Cardiologia
  47. The Impact of Positive Inotropic Therapy on Hemodynamics and Organ Function in Acute Heart Failure: A Differentiated View
    Juan Cheko, Nikolaos Patsalis, Julian Kreutz, Dimitar Divchev, Georgios Chatzis, Bernhard Schieffer, Birgit Markus · 2023 · Journal of Personalized Medicine
  48. Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Palestine: Retrospective clinical audit study
    Ammar Abdulrahman Jairoun, Sabaa Saleh Al‐Hemyari, Moyad Jamal Shahwan, Sa’ed H. Zyoud, Maimona Jairoun · 2024 · Saudi Pharmaceutical Journal
  49. Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fraction
    Alexander Schmitt, Michael Behnes, Kathrin Weidner, Mohammad Abumayyaleh, Marielen Reinhardt, Noah Abel, Felix Lau, Jan Forner, Mohamed Ayoub, Kambis Mashayekhi et al. · 2024 · Clinical Research in Cardiology
  50. Long-Term Maintenance of Normal Serum Vitamin B1 Levels Is Associated with Better Outcomes in Patients with Heart Failure
    Junko Morimoto, Keisuke Satogami, Takaya Naraoka, Akira Taruya, Atsushi Tanaka · 2024 · International Heart Journal
  51. Machine learning in the prevention of heart failure
    Arsalan Hamid, Matthew W. Segar, Biykem Bozkurt, Carlos G. Santos‐Gallego, Vijay Nambi, Javed Butler, Michael E. Hall, Marat Fudim · 2024 · Heart Failure Reviews
  52. The emerging role of artificial intelligence in heart failure
    Brett Sydney Bernstein, Sona Streather, Kevin O’Gallagher · 2025 · Future Cardiology
  53. Neues zur Herzinsuffizienz
    Jan Wintrich, Ingrid Kindermann, Michael Böhm · 2018 · Herz
  54. Conduction disturbances after transcatheter aortic valve implantation
    Alicia Calvo-Fernández, Iris Rodríguez-Costoya, Helena Tizón‐Marcos, Beatriz Vaquerizo · 2019 · REC CardioClinics
  55. Caracterización sociodemográfica, clínica y terapéutica de pacientes con falla cardiaca con fracción de eyección intermedia: cohorte MED-ICAi
    Kevin Y. Ruales-Mora, Tatiana Rojas López, Julio Cesar Valencia-Maturana, Irene Salas-Giraldo, Luis M. Ruiz-Peña, Marly García-Sánchez, Andrés Zapata–Cárdenas · 2021 · Revista Colombiana de Cardiología
  56. J-ACCESS investigation and nuclear cardiology in Japan: implications for heart failure
    Kenichi Nakajima, Tsunehiko Nishimura · 2023 · Annals of Nuclear Medicine
  57. Impact of Atrial Fibrillation on Cerebro-Cardiovascular Outcome of Heart Failure with Mildly-Reduced Ejection Fraction
    Na Li, Yunlong Zhu, Fangqun Cheng, Yongliang Chen, Xin Peng, Mingxing Wu, Haobo Huang, Lingling Zhang, Min Liao, Sha Xiao et al. · 2023 · ESC Heart Failure
  58. Systolic heart failure: A review of clinical status and meta-analysis of diagnosis and clinical management methods
    Aref Albakri · 2018 · Trends in Research
  59. Coexisting Morbidities in Heart Failure: No Robust Interaction with the Left Ventricular Ejection Fraction
    Andrew V. Xanthopoulos, Apostolos K Dimos, Grigorios Giamouzis, Angeliki Bourazana, Alexandros Zagouras, Michail Papamichalis, Takeshi Kitai, John S. Skoularigis, Filippos K. Triposkiadis · 2020 · Current Heart Failure Reports
  60. Acute myocardial infarction and acute heart failure among renal transplant recipients: a national readmissions database study
    Tanveer Mir, Mohammed Uddin, Waqas Qureshi, Tarec Micho Ulbeh, Salik Nazir, Asim Kichloo, Mohammed Amir Babu, Waqas Ullah, Yasar Sattar, Shady Abohashem et al. · 2022 · Journal of Nephrology
  61. Iron deficiency in heart failure
    Lars H. Lund, Gianluigi Savarese, Ulf Dahlström · 2019 · International Journal of Cardiology
  62. Extending Behavioral Medicine to Heart Failure With Preserved Ejection Fraction
    Kristie M. Harris, Jeffrey Moore Testani, Matthew M. Burg · 2020 · Psychosomatic Medicine
  63. Cautious optimism for machine learning techniques for prediction of heart failure outcomes
    Nowell Mark Fine, Jonathan G. Howlett · 2021 · European Journal of Heart Failure
  64. Liver, kidney, blood, and joints: the underestimated impact of non-cardiac comorbidities in acute heart failure
    Marcus Dörr · 2023 · European Journal of Preventive Cardiology
  65. Exploring the evidence gap: Loop diuretic withdrawal in chronic heart failure
    Aurora Andrade · 2024 · Revista Portuguesa de Cardiologia
  66. The heart failure and diabetes combo: higher risk, less care?
    Tobias Schupp, İbrahim Akın, Michael Behnes · 2025 · European Journal of Preventive Cardiology
  67. Differentiating Characteristics and Responses to Treatment of New-Onset Heart Failure With Preserved and Reduced Ejection Fraction in Ambulatory Patients
    Osama Alhadramy, Refal A. Alahmadi, Afrah M. Alameen, Nada S. Ashmawi, Nadeen A. Alrehaili, Rahaf A. Afandi, Tahani A. Alrehaili, Saba Kassim · 2023 · Cardiology Research
  68. Prognostic role of renal replacement therapy among hospitalized patients with heart failure in the Brazilian national public health system
    Andréa Coy‐Canguçu, Lígia M. Antunes‐Correa, Marilda Mazzali, Paula Abrão, Fernanda Ronco, Cínthia Montenegro Teixeira, Karynna Pimentel Viana, Guilherme Cordeiro, Maurício Longato, Otávio Rizzi Coelho et al. · 2023 · Frontiers in Cardiovascular Medicine
  69. Respiratory Muscle Strength and Quality of Life in Patients With Heart Failure and Their Main Correlated Factors
    Isis Marinho de Noronha, Larisse Xavier Almeida, Nina Vitória de Souza Silva Andrade, Eduardo França, José Heriston de Morais Lima, Rafaela Pedrosa, Fernanda Gabriella de Siqueira Barros Nogueira, Tatiana Onofre · 2023 · The Journal of Cardiovascular Nursing
  70. Three-Year Outcomes Based on Left Ventricular Ejection Fraction in Patients With Non-ST-Segment Elevation Myocardial Infarction Undergoing Newer-Generation Drug-Eluting Stent Implantation
    Yong Hoon Kim, Ae‐Young Her, Seung‐Woon Rha, Cheol Ung Choi, Byoung Geol Choi, Su Jin Hyun, Soohyung Park, Dong Oh Kang, Jung Rae Cho, Min-Woong Kim et al. · 2024 · Journal of Cardiovascular Intervention
  71. Reparación de borde a borde de la válvula tricúspide y hospitalizaciones por insuficiencia cardiaca: registro TRI-SPA
    Julio Echarte‐Morales, Laura Sanchís, Dabit Arzamendi, Vanessa Moñivas, Fernando Carrasco‐Chinchilla, Manuel Pan, Luis Nombela-Franco y, Isaac Pascual, Tomás Benito‐González, Ruth M. Perez et al. · 2025 · Revista Española de Cardiología
  72. Prior hospitalizations as a predictor of prognosis in heart failure with mildly reduced ejection fraction
    Henning Johann Steffen, Michael Behnes, Alexander Schmitt, Noah Abel, Felix Lau, Marielen Reinhardt, Muharrem Akin, Thomas Bertsch, Mohamed Ayoub, Kambis Mashayekhi et al. · 2025 · Clinical Research in Cardiology
  73. Mortality and Economic Impact of Heart Failure
    Aaron Scott Gillet, Garrick C. Stewart · 2025 · Medical Clinics of North America
  74. Development and validation of a clinical prediction model for in-hospital heart failure risk following PCI in patients with coronary artery disease
    Zhenlian Ning, Bing Li, Ziming Ning, Beili Zhu, Mengfan Zhao, Bin Huang · 2025 · PLoS ONE
  75. CHA2DS2-VASc score as a mortality predictor in acute heart failure with preserved ejection fraction
    Olaf Kądzioła, Konrad Stępień, Alicia Del Carmen Yika, Maria Kurek, Natalia Kachnic, Aleksandra Karcińska, Michael Platschek, Zuzanna Wyleciał, Karol Witold Nowak, Aleksander Siniarski et al. · 2025 · Frontiers in Cardiovascular Medicine
  76. The changing landscape of heart failure: translating management into the modern era
    Cristina Madaudo, Wasyla Ibrahim, Daniela Noakes, Daniel I. Bromage, Gianfranco Sinagra, Theresa McDonagh, Antonio Nicola Cannata · 2025 · European Journal of Internal Medicine
  77. Rationale and design of a randomized, sham-controlled, clinical trial for evaluation of the Edwards APTURE transcatheter shunt system (ALT-FLOW II)
    Dean J. Kereiakes, Ryan James Tedford, JoAnn M. Lindenfeld, William A. Gray, Firas E. Zahr, Philipp C. Lurz, Benjamin M. Hibbert, Suzanne J. Baron, João L. Cavalcante, Ulrich P. Jorde et al. · 2026 · European Journal of Heart Failure
  78. Healthcare utilization and costs in the first two years after heart failure diagnosis: an observational study by phenotype in southwestern Sweden
    Jason Davidge, Anders Halling, Björn Agvall · 2026 · BMC Health Services Research
  79. Mitral regurgitation in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF
    Misato Chimura, Kieran F. Docherty, Pardeep S. Jhund, Mingming Yang, Ryohei Ono, Alasdair David Henderson, John G.F. Cleland, Marco Metra, Genzhou Liu, Punag Divanji et al. · 2026 · European Journal of Heart Failure
  80. An expert opinion on heart failure in hypertensive heart disease
    Javier Dı́ez, Arantxa González, Annet Kirabo, Paolo Verdecchia, Tazeen H. Jafar, Dagfinn Aune, Luke Joseph Laffin, Thilo Burkard, Giuseppe M.C. Rosano, Massimo Francesco Piepoli et al. · 2026 · European Journal of Heart Failure
  81. Guideline-Directed Heart Failure Pharmacotherapy in Adults Aged ≥75 Years: Evidence Gaps, Tolerability, and Implications for Clinical Practice
    Rémi Esser, Olivier Maurou, Marine Larbaneix, Alejandro Mondragon, Marlène Esteban, Christine Farges, Vincenzo Palermo, Nicolas Pages, Sophie Nisse-Durgeat, Marc Harboun · 2026 · Drugs & Aging
  82. Prognostic value of the De Ritis ratio for 1-year major adverse cardiovascular events in elderly patients with acute decompensated heart failure
    Truong Huy Hoang, Dan Van Buu, Nguyen Khoi DANG, Thao Le Phuong Nguyen · 2026 · Asian Biomedicine
  83. Temporal Trends and Predictors of Mortality in Heart Failure with Reduced Ejection Fraction: The Role of Renal Function and Left Ventricular Improvement
    Andrea López‐López, Estefanía Rivas Vázquez, Margarita Regueiro‐Abel, Carmen Cristina Álvarez-Suárez, Charigan Abou Johk-Casas, Juliana Elices‐Teja, Ramón Ríos Vázquez, German Santamarina, Carlos González‐Juanatey · 2026 · Journal of Clinical Medicine
  84. Herzinsuffizienz im Alter
    Anne Lambrecht, Roland Hardt · 2019 · Zeitschrift für Gerontologie und Geriatrie
  85. Theoretical and practical aspects of the use of biomarkers in chronic heart failure
    Denys Babichev, Iurii Stepanovich Rudyk, O Medentseva · 2021 · Ukrainian Therapeutical Journal
  86. Relationship between Exercise Test Parameters, Device-Delivered Electric Shock and Adverse Clinical Events in Patients with an Implantable Cardioverter Defibrillator for Primary Prevention
    Guillaume Théry, Laurent Faroux, Fanny Boyer, Pierre Nazeyrollas, Jean Pierre Chabert, Damien Metz, François Lesaffre · 2023 · Journal of Personalized Medicine
  87. Leveraging 3D Echocardiograms to Evaluate AI Model Performance in Predicting Cardiac Function on Out-of-Distribution Data
    Grant Duffy, Kai Christensen, David Ouyang · 2023 · Pacific Symposium on Biocomputing (PSB)
  88. Unusual Presentations of Thyrotoxic Tricuspid and Mitral Regurgitations in 62 Adults: A Systematic Review of Case Reports with In-depth Pathophysiological Review
    Andro Pramana Witarto, Bendix Samarta Witarto, Shidi Laras Pramudito, Lintang Cahyaning Ratri, Della Anastasia Candra, Stephanie Wirakasa, Hermina Novida, Hendri Susilo, Citrawati Dyah Kencono Wungu, Maya Kusumawati · 2024 · European Cardiology Review
  89. Outcomes of patients with heart failure in Türkiye
    Anıl Şahin, Mehmet Birhan Yılmaz, Ahmet Çelik, Tuğçe Çöllüoğlu, Dilek Ural, Lale Dinç Asarcıklı, Sanem Nalbantgil, Emre Demir, Yüksel Çavuşoğlu, Selda Murat et al. · 2024 · TURKISH JOURNAL OF MEDICAL SCIENCES
  90. The association of reduced ejection fraction with the outcomes of endovascular abdominal aortic aneurysm repair
    Kirthi S. Bellamkonda, Cheryl K. Zogg, Nihar Desai, David S. Strosberg, David H. Stone, Raul J. Guzman, Cassius Iyad Ochoa Chaar · 2024 · Journal of Vascular Surgery
  91. Características clínicas y tratamiento farmacológico de los pacientes con insuficiencia cardíaca en una cohorte de atención primaria
    Maria Giner‐Soriano, Ramon Monfà, Roser Vives, Silvia Fernández-García, Antonio Vallano, Rosa Morros · 2025 · Atención Primaria
  92. Non-Invasive Measurement of Hemodynamic Parameters via Whole-Body Impedance Cardiography Among Hospitalized Heart Failure Patients: An Effective Alternative to Invasive Right Heart Catheterization?
    Felix Ausbuettel, Sabah Khwamurad, Murad Haj Abdo, Sebastian Kerber, Karin Nentwich, Martina B. Hautmann, Sebastian Barth · 2025 · Journal of Cardiovascular Development and Disease
  93. The impact of diabetes duration and glycemic control on ejection fraction in heart failure patients
    Omer Dogan, Hasan Ali Barman, Ebru Serin, Abdullah Ömer Ebeoğlu, Adem Atıcı, Ridvan Turkmen, Ibrahim Temel, Isilay Kok, Omer Gok, İpek Aydın et al. · 2025 · Acta Diabetologica
  94. Native QRS duration and outcomes in heart failure with mildly reduced ejection fraction: results from a large-scaled registry
    Finn Ole Kronberg, Michael Behnes, Marielen Reinhardt, Noah Abel, Alexander Schmitt, Felix Lau, Thomas Bertsch, Henning Johann Steffen, Kathrin Weidner, Mohammad Abumayyaleh et al. · 2025 · Clinical Research in Cardiology
  95. Pharmacotherapy Post-Cardiac Resynchronization Therapy: Long Walk Home
    David Žižek, Marta Cvijić, Mitja Lainščak · 2025 · European Journal of Heart Failure
  96. Impact of Tricuspid Regurgitation on the Clinical Outcomes of Patients with Heart Failure
    Muhammad Usman Almani, Rasha Khan, Noor E Fatima, Muhammad Yousuf, Aman M. Amanullah · 2025 · Public Health Challenges
  97. Outcome of Functional Mitral Regurgitation Associated With Heart Failure with Mildly Reduced or Preserved Ejection Fraction
    Ga Yun Kim, So-Min Lim, Sahmin Lee, Byung Joo Sun, Jong‐Min Song, Duk‐Hyun Kang · 2025 · The American Journal of Cardiology
  98. Practical and methodological aspects of managing a registry to assess the quality of health care for patients with heart failure. A systematic review
    Olga Mikhailovna Posnenkova, Т. М. Богданова, Alexander Fedonnikov · 2025 · Russian Journal of Cardiology
  99. Factors Associated with Mortality in Patients with Chronic Heart Failure During an 18-Month Follow-up Period
    Olesya A. Rubanenko, А. О. Рубаненко, Inna Skripnik, Kristina Matyukhina, Igor Davydkin, Dmitry Duplyakov · 2025 · Russian Open Medical Journal
  100. Efficacy and safety of Qiliqiangxin capsule as adjunctive therapy in heart failure with reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials
    Yuxuan Li, Tianshi Mao, Xinyan Qu, Long Xie, Peng Li, Bairu Cheng, Dingyuan Zhang, Sinai Li, Dong Li, Qian Lin · 2026 · Journal of Ethnopharmacology